Fabio Angeli

Responsabile di servizio

Pubblicazioni

•  Angeli F, Verdecchia P, Reboldi GP, et al. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. Am J Hypertens. 2004.
• Angeli F, Verdec-chia P, Reboldi GP et al. Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. Am J Cardiol. 2004;
• Angeli F, Verdecchia P, Pellegrino C, et al. Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension. 2003;
• Verdecchia P, Staessen JA, Angeli F, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients withhypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;
• Angeli F, Verdecchia P, Karthikeyan G, et al. Beta-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs. 2010;
• Angeli F, Reboldi G, Garofoli M, et al. Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. Acute Card Care. 2012;
• Angeli F, Verdecchia P, Savonitto S, et al. Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. Catheter Cardiovasc Interv. 2014;
• Angeli F, Verdecchia P, Iacobellis G, et al. Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol. 2014;
• Angeli F, Verdec-chia P, Savonitto S, et al. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention. EuroIntervention. 2015;
• Angeli F, Cavallini C, Verdecchia P, et al. A risk score for predicting 1-year mortality in patients ≥75 years of age presenting with non-ST-elevation acute coronary syndrome. Am J Cardiol. 2015.